DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE
According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosph...
Saved in:
Main Authors | , , , , , , , , , , , , , , , |
---|---|
Format | Patent |
Language | English Spanish |
Published |
10.02.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and/or therapeutic agent as well as a prophylactic and/or therapeutic method for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure.
La presente invención proporciona un derivado de dihidropiridazin-3,5-diona o una sal del mismo, o un solvato del compuesto o la sal, un fármaco farmacéutico, una composición farmacéutica, un inhibidor del transportador de fosfato dependiente de sodio y un agente de prevención y/o terapéutico para la hiperfosfatemia, hiperparatiroidismo secundario, e insuficiencia renal crónica, que comprende el compuesto como un ingrediente activo, y un método para la prevención y/o tratamiento. |
---|---|
AbstractList | According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also provided are the following that contain any of said compounds as an active ingredient: a drug, a drug composition, a sodium-dependent phosphate transporter inhibitor, and a prophylactic and/or therapeutic agent as well as a prophylactic and/or therapeutic method for hyperphosphatemia, secondary hyperparathyroidism, and chronic renal failure.
La presente invención proporciona un derivado de dihidropiridazin-3,5-diona o una sal del mismo, o un solvato del compuesto o la sal, un fármaco farmacéutico, una composición farmacéutica, un inhibidor del transportador de fosfato dependiente de sodio y un agente de prevención y/o terapéutico para la hiperfosfatemia, hiperparatiroidismo secundario, e insuficiencia renal crónica, que comprende el compuesto como un ingrediente activo, y un método para la prevención y/o tratamiento. |
Author | HORIBA, NAOSHI OHTOMO, SHUICHI HARADA, TAKEO OKAMOTO, NAOKI ONO, YOSHIYUKI MURATA, YOSHIHISA KASWIWAGI, HIROTAKA IDE, MITSUAKI OHTAKE, YOSHIHITO KIMBARA, ATSUSHI ICHIDA, YASUHIRO TACHIBANA, KAZUTAKA MIZUGUCHI, EISAKU HORI, NOBUYUKI TANAKA, SHOTA NOMURA, KENICHI |
Author_xml | – fullname: HORI, NOBUYUKI – fullname: HORIBA, NAOSHI – fullname: HARADA, TAKEO – fullname: KASWIWAGI, HIROTAKA – fullname: MURATA, YOSHIHISA – fullname: ONO, YOSHIYUKI – fullname: OHTOMO, SHUICHI – fullname: OKAMOTO, NAOKI – fullname: TACHIBANA, KAZUTAKA – fullname: IDE, MITSUAKI – fullname: MIZUGUCHI, EISAKU – fullname: ICHIDA, YASUHIRO – fullname: OHTAKE, YOSHIHITO – fullname: KIMBARA, ATSUSHI – fullname: NOMURA, KENICHI – fullname: TANAKA, SHOTA |
BookMark | eNrjYmDJy89L5WRQc_H0iHQJ8g-IDPJ0cYzy9HPVNdYx1XXx9PdzVXBxDfIMcwzxDHPlYWBNS8wpTuWF0twMSm6uIc4euqkF-fGpxQWJyal5qSXxvhFGBoamBoZGpsbmjsZEKQIA9-0lyw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | DERIVADOS DE DIHIDROPIRIDAZIN-3,5-DIONA. |
ExternalDocumentID | MX2015012537A |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_MX2015012537A3 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 12:48:31 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English Spanish |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_MX2015012537A3 |
Notes | Application Number: MX20150012537 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160210&DB=EPODOC&CC=MX&NR=2015012537A |
ParticipantIDs | epo_espacenet_MX2015012537A |
PublicationCentury | 2000 |
PublicationDate | 20160210 |
PublicationDateYYYYMMDD | 2016-02-10 |
PublicationDate_xml | – month: 02 year: 2016 text: 20160210 day: 10 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | CHUGAI SEIYAKU KABUSHIKI KAISHA |
RelatedCompanies_xml | – name: CHUGAI SEIYAKU KABUSHIKI KAISHA |
Score | 2.8855243 |
Snippet | According to the present invention, provided are a dihydropyridazine-3,5-dione derivative, a salt thereof, and solvates of the derivative and of the salt. Also... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
Title | DIHYDROPYRIDAZINE-3,5-DIONE DERIVATIVE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160210&DB=EPODOC&locale=&CC=MX&NR=2015012537A |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_mFPVNp6JOZYj0yeJmmtY-FOmallboB6WWzpfR1gxE0GEr_vteQqd72lvIQT4Ofnf5JZc7gJtxSbjJzVIV2exECbNKRQpWqpXBa_KKHnwh7zvCSPeftaeCFj14X_2FkXlCf2RyRERUjXhvpb1e_l9iMRlb2dxVb9j1-ehlFlM6djzRBYVR2NRyk5jFjuI4VlgoUSpkFG0xJYa9Bdt4jjYEHNx8Kr6lLNd9incAOwkO99EeQo83A9hzVqXXBrAbdi_e2OzA1xyBwgJ_xtI4maUBs1-CyFXJLVUZWkN3xJCQ5XYW5O4xXHtu5vgqTjj_2948LNYWR06gj7yfn8II-yrOqUm5TjTtvjQfkDmSCbrY2iyNBT-D4YaBzjdKh7AvtCXCjyfjC-i3X9_8Er1rW11JrfwCPv54ig |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ7Uaqw3rRq1PhpjOEksbgE5EENZCGh5hCChvRDAbWJMtBGMf99ZQrWn3jY7yT4m-Wb2252dAbgZ5YRpTMtFns2OlzArRKRguViorCSv6MEXzX2H5yvOy_gpldMOvK_-wjR5Qn-a5IiIqBLxXjf2evl_iUWb2MrqrnjDrs9HO9ap0LJjSeEURqAT3QoDGpiCaepeKvgRl8loi2WiGluwjWdslcPBSib8W8py3afY-7AT4nAf9QF0WNWHnrkqvdaHXa998cZmC77qEATqOjMaBeEscqkxd31LJLeySNEaWkOKhCwxYjexjuDatmLTEXHC7G97mZeuLY4cQxd5PzuBIfYVjMmazBQyHt_n2gMyRyKhiy21XF2wUxhsGOhso_QKek7sTbOp6z8PYI9rjociS6Nz6NZf3-wCPW1dXDYa-gURVHt9 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=DIHYDROPYRIDAZINE-3%2C5-DIONE+DERIVATIVE&rft.inventor=HORI%2C+NOBUYUKI&rft.inventor=HORIBA%2C+NAOSHI&rft.inventor=HARADA%2C+TAKEO&rft.inventor=KASWIWAGI%2C+HIROTAKA&rft.inventor=MURATA%2C+YOSHIHISA&rft.inventor=ONO%2C+YOSHIYUKI&rft.inventor=OHTOMO%2C+SHUICHI&rft.inventor=OKAMOTO%2C+NAOKI&rft.inventor=TACHIBANA%2C+KAZUTAKA&rft.inventor=IDE%2C+MITSUAKI&rft.inventor=MIZUGUCHI%2C+EISAKU&rft.inventor=ICHIDA%2C+YASUHIRO&rft.inventor=OHTAKE%2C+YOSHIHITO&rft.inventor=KIMBARA%2C+ATSUSHI&rft.inventor=NOMURA%2C+KENICHI&rft.inventor=TANAKA%2C+SHOTA&rft.date=2016-02-10&rft.externalDBID=A&rft.externalDocID=MX2015012537A |